|
1
|
Felding-Habermann B, Habermann R, Saldivar
E and Ruggeri ZM: Role of beta3 integrins in melanoma cell adhesion
to activated platelets under flow. J Biol Chem. 271:5892–5900.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Borsig L, Wong R, Feramisco J, et al:
Heparin and cancer revisited: mechanistic connections involving
platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc
Natl Acad Sci USA. 98:3352–3357. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Labelle M, Begum S and Hynes RO: Direct
signaling between platelets and cancer cells induces an
epithelial-mesenchymal-like transition and promotes metastasis.
Cancer Cell. 20:576–590. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Buergy D, Wenz F, Groden C and Brockmann
MA: Tumor-platelet interaction in solid tumors. Int J Cancer.
130:2747–2760. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rao AK and Rao DA: Platelets signal and
tumors take off. Blood. 120:4667–4668. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Douglas VK, Tallman MS, Cripe LD and
Peterson LC: Thrombopoietin administered during induction
chemotherapy to patients with acute myeloid leukemia induces
transient morphologic changes that may resemble chronic
myeloproliferative disorders. Am J Clin Path. 117:844–850. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stone RL, Nick AM, McNeish IA, et al:
Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med.
366:610–618. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang-Tilz Y, Tilz C, Wang B, Tilz GP and
Stefan H: Influence of lamotrigine and topiramate on MDR1
expression in difficult-to-treat temporal lobe epilepsy. Epilepsia.
47:233–239. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ma S, Liu X, Geng JG and Guo SW: Increased
SLIT immunoreactivity as a biomarker for recurrence in endometrial
carcinoma. Am J Obstet Gynecol. 202:68e61–e68. e112010. View Article : Google Scholar
|
|
10
|
Feng W, Madajka M, Kerr BA, et al: A novel
role for platelet secretion in angiogenesis: mediating bone
marrow-derived cell mobilization and homing. Blood. 117:3893–3902.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Manetta A, Satyaswaroop PG, Hamilton T, et
al: Radio imaging of human ovarian carcinoma xenograft in nude
mice. Gynecol Oncol. 28:292–299. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Holmes CE, Levis JE and Ornstein DL:
Activated platelets enhance ovarian cancer cell invasion in a
cellular model of metastasis. Clin Exp Metastasis. 26:653–661.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Trikha M, Zhou Z, Timar J, et al: Multiple
roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor
growth, angiogenesis, and metastasis. Cancer Res. 62:2824–2833.
2002.PubMed/NCBI
|
|
14
|
Dardik R, Savion N, Kaufmann Y and Varon
D: Thrombin promotes platelet-mediated melanoma cell adhesion to
endothelial cells under flow conditions: role of platelet
glycoproteins P-selectin and GPIIb-IIIA. Br J Cancer. 77:2069–2075.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Matsui H, Harada I and Sawada Y: Src,
p130Cas, and Mechanotransduction in Cancer Cells. Genes Cancer.
3:394–401. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nick AM, Stone RL, Armaiz-Pena G, et al:
Silencing of p130cas in ovarian carcinoma: a novel mechanism for
tumor cell death. J Natl Cancer Inst. 103:1596–1612. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sawada Y, Tamada M, Dubin-Thaler BJ, et
al: Force sensing by mechanical extension of the Src family kinase
substrate p130Cas. Cell. 127:1015–1026. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang P, Guo A, Possemato A, et al:
Identification and functional characterization of p130Cas as a
substrate of protein tyrosine phosphatase nonreceptor 14. Oncogene.
32:2087–2095. 2013. View Article : Google Scholar :
|
|
19
|
Chatzizacharias NA, Kouraklis GP and
Theocharis SE: Clinical significance of FAK expression in human
neoplasia. Histol Histopathol. 23:629–650. 2008.PubMed/NCBI
|
|
20
|
Goel HL and Mercurio AM: VEGF targets the
tumour cell. Nat Rev Cancer. 13:871–882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Prow D and Vadhan-Raj S: Thrombopoietin:
biology and potential clinical applications. Oncology (Williston
Park). 12:1597–1604. 1607–1598; discussion 1611–1594. 1998.
|
|
23
|
Dardik R, Kaufmann Y, Savion N, et al:
Platelets mediate tumor cell adhesion to the subendothelium under
flow conditions: involvement of platelet GPIIb-IIIa and tumor cell
alpha(v) integrins. Int J Cancer. 70:201–207. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Konstantopoulos K and Thomas SN: Cancer
cells in transit: the vascular interactions of tumor cells. Annu
Rev Biomed Eng. 11:177–202. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McCarty OJ, Mousa SA, Bray PF and
Konstantopoulos K: Immobilized platelets support human colon
carcinoma cell tethering, rolling, and firm adhesion under dynamic
flow conditions. Blood. 96:1789–1797. 2000.PubMed/NCBI
|
|
26
|
Ay C, Dunkler D, Pirker R, et al: High
D-dimer levels are associated with poor prognosis in cancer
patients. Haematologica. 97:1158–1164. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dirix LY, Salgado R, Weytjens R, et al:
Plasma fibrin D-dimer levels correlate with tumour volume,
progression rate and survival in patients with metastatic breast
cancer. Br J Cancer. 86:389–395. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zigler M, Kamiya T, Brantley EC, Villares
GJ and Bar-Eli M: PAR-1 and thrombin: the ties that bind the
microenvironment to melanoma metastasis. Cancer Res. 71:6561–6566.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cowell LN, Graham JD, Bouton AH, Clarke CL
and O’Neill GM: Tamoxifen treatment promotes phosphorylation of the
adhesion molecules, p130Cas/BCAR1, FAK and Src, via an
adhesion-dependent pathway. Oncogene. 25:7597–7607. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McLean GW, Carragher NO, Avizienyte E, et
al: The role of focal-adhesion kinase in cancer - a new therapeutic
opportunity. Nat Rev Cancer. 5:505–515. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ward KK, Tancioni I, Lawson C, et al:
Inhibition of focal adhesion kinase (FAK) activity prevents
anchorage-independent ovarian carcinoma cell growth and tumor
progression. Clin Exp Metastasis. 30:579–594. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen XL, Nam JO, Jean C, et al:
VEGF-induced vascular permeability is mediated by FAK. Dev Cell.
22:146–157. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Erler JT, Bennewith KL, Nicolau M, et al:
Lysyl oxidase is essential for hypoxia-induced metastasis. Nature.
440:1222–1226. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kirschmann DA, Seftor EA, Fong SF, et al:
A molecular role for lysyl oxidase in breast cancer invasion.
Cancer Res. 62:4478–4483. 2002.PubMed/NCBI
|
|
35
|
Baker AM, Bird D, Lang G, Cox TR and Erler
JT: Lysyl oxidase enzymatic function increases stiffness to drive
colorectal cancer progression through FAK. Oncogene. 32:1863–1868.
2013. View Article : Google Scholar
|
|
36
|
Baker AM, Cox TR, Bird D, et al: The role
of lysyl oxidase in SRC-dependent proliferation and metastasis of
colorectal cancer. J Natl Cancer Inst. 103:407–424. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lapointe J, Li C, Higgins JP, et al: Gene
expression profiling identifies clinically relevant subtypes of
prostate cancer. Proc Natl Acad Sci USA. 101:811–816. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Battegay EJ, Rupp J, Iruela-Arispe L, Sage
EH and Pech M: PDGF-BB modulates endothelial proliferation and
angiogenesis in vitro via PDGF beta-receptors. J Cell Biol.
125:917–928. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Anglesio MS, George J, Kulbe H, et al:
IL6-STAT3-HIF signaling and therapeutic response to the
angiogenesis inhibitor sunitinib in ovarian clear cell cancer. Clin
Cancer Res. 17:2538–2548. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Harker LA, Marzec UM, Kelly AB, et al:
Prevention of thrombocytopenia and neutropenia in a nonhuman
primate model of marrow suppressive chemotherapy by combining
pegylated recombinant human megakaryocyte growth and development
factor and recombinant human granulocyte colony-stimulating factor.
Blood. 89:155–165. 1997.PubMed/NCBI
|
|
41
|
Grossmann A, Lenox J, Ren HP, et al:
Thrombopoietin accelerates platelet, red blood cell, and neutrophil
recovery in myelosuppressed mice. Exp Hematol. 24:1238–1246.
1996.PubMed/NCBI
|
|
42
|
Bergmeier W, Piffath CL, Goerge T, et al:
The role of platelet adhesion receptor GPIbalpha far exceeds that
of its main ligand, von Willebrand factor, in arterial thrombosis.
Proc Natl Acad Sci USA. 103:16900–16905. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cho MS, Bottsford-Miller J, Vasquez HG, et
al: Platelets increase the proliferation of ovarian cancer cells.
Blood. 120:4869–4872. 2012. View Article : Google Scholar : PubMed/NCBI
|
